The same result was observed in the GEO dataset when adjusting for other clinical features, including sex, age ALT, AFP, cirrhosis, BCLC staging, CLIP staging and TNM staging (high-risk group vs. low-risk group, HR = 1.69, 95% CI [1.06–2.70], P = 0.03, n = 221, Table 3). The gene discussed is GPT; the disease is Cirrhosis.